Jiangsu Simcere Pharmaceutical Co., Ltd. sell "Enlength"
Basic Information
188
13
4
3.6(35)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Enlength
Details
Manufacturer(s)
Specifications
- Indication: Bortezomib, a cornerstone treatment for multiple myeloma used across induction, consolidation and maintenance therapy
- Regulatory Approval Status: Recommended in 2020 as a first-line drug for multiple myeloma management in China's Guidelines for Diagnosis and Treatment of Multiple Myeloma, and included in the National Drug Reimbursement List (NDRL)
- Storage Conditions: Store in a tightly sealed container in a cool, dry place, protected from light and moisture
Other Information
Additional Description:
Bortezomib is a cornerstone treatment for multiple myeloma, used across induction, consolidation, and maintenance therapy. In 2020 it was recommended as a first-line drug for comprehensive multiple myeloma management in China's Guidelines for Diagnosis and Treatment of Multiple Myeloma and was added to the National Drug Reimbursement List (NDRL).
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment